Product Information
BUPRENORPHINE 5 MCG/HR PATCH is a generic product labeled by Alvogen Inc., priced at $20.9308 per EA under NDC 47781040604. Its NADAC has been published 172 times since Nov 9, 2022.
FDA first approved this application on May 17, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 ug/h
Manufacturer
Alvogen Inc.NDC
47781040604
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
2/18/2026
Active Ingredients
BUPRENORPHINEApproval Type
Generic (ANDA)
FDA Application
ANDA207490FDA Approved
5/17/2022
TE Code
AB
On Market Since
5/17/2022
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 5 MCG/HR PATCH has been published 172 times since Nov 9, 2022, and over the history we have for it it has declined 24.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.9308 per EA |
|---|---|
| All-time high | $37.9656 (Dec 13, 2023) |
| All-time low | $19.0169 (May 22, 2024) |
| 52-week high | $22.5775 |
| 52-week low | $20.8863 |
| Median price | $22.5775 |
| Average price | $25.4906 |
| Largest weekly change | -32.9% (Jun 21, 2023) |
| Weeks tracked | 172 |
| Tracking since | Nov 9, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-2.4%
3Y
-31.3%
5Y
N/A
All
-24.9%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 5 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 5 MCG/HR PATCH, manufactured by Alvogen Inc., is $20.9308 per EA (NDC 47781040604), effective Feb 18, 2026.
How has the price of BUPRENORPHINE 5 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 5 MCG/HR PATCH has declined 24.9%. It has been tracked across 172 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 5 MCG/HR PATCH?
Since Nov 9, 2022, the NADAC for BUPRENORPHINE 5 MCG/HR PATCH has ranged from a low of $19.0169 (May 22, 2024) to a high of $37.9656 (Dec 13, 2023), with a median of $22.5775 per EA.
Are there cheaper alternatives to BUPRENORPHINE 5 MCG/HR PATCH?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE 5 MCG/HR PATCH in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPRENORPHINE 5 MCG/HR PATCH?
BUPRENORPHINE 5 MCG/HR PATCH (NDC 47781040604) is labeled by Alvogen Inc., and CMS classifies it as a generic product.